After Ranbaxy And Caraco, FDA Cracks Down On Lupin, Finds Lapses At India Site
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalosporin and ACE inhibitor generics company says it has addressed eight of 15 deficiencies cited by FDA.